ArticlePLoS pathogens2009

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.

Reem Berro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.